Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5866 | 1495 | 34.7 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
272 | 18537 | VITAMIN D//25 HYDROXYVITAMIN D//VITAMIN D DEFICIENCY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ED 71 | Author keyword | 45 | 90% | 1% | 19 |
2 | ELDECALCITOL | Author keyword | 36 | 77% | 2% | 24 |
3 | 19 NORVITAMIN D | Author keyword | 26 | 100% | 1% | 11 |
4 | BONE CALCIUM METAB | Address | 24 | 91% | 1% | 10 |
5 | CALCEMIC ACTIVITY | Author keyword | 23 | 100% | 1% | 10 |
6 | C 3 EPIMERIZATION PATHWAY | Author keyword | 18 | 89% | 1% | 8 |
7 | VITAMIN D ANALOGS | Author keyword | 14 | 28% | 3% | 43 |
8 | 1 ALPHA 25 DIHYDROXY 2 BETA 3 HYDROXYPROPOXYVITAMIN D 3 | Author keyword | 14 | 100% | 0% | 7 |
9 | 2MD | Author keyword | 12 | 86% | 0% | 6 |
10 | C 24 OXIDATION PATHWAY | Author keyword | 12 | 86% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ED 71 | 45 | 90% | 1% | 19 | Search ED+71 | Search ED+71 |
2 | ELDECALCITOL | 36 | 77% | 2% | 24 | Search ELDECALCITOL | Search ELDECALCITOL |
3 | 19 NORVITAMIN D | 26 | 100% | 1% | 11 | Search 19+NORVITAMIN+D | Search 19+NORVITAMIN+D |
4 | CALCEMIC ACTIVITY | 23 | 100% | 1% | 10 | Search CALCEMIC+ACTIVITY | Search CALCEMIC+ACTIVITY |
5 | C 3 EPIMERIZATION PATHWAY | 18 | 89% | 1% | 8 | Search C+3+EPIMERIZATION+PATHWAY | Search C+3+EPIMERIZATION+PATHWAY |
6 | VITAMIN D ANALOGS | 14 | 28% | 3% | 43 | Search VITAMIN+D+ANALOGS | Search VITAMIN+D+ANALOGS |
7 | 1 ALPHA 25 DIHYDROXY 2 BETA 3 HYDROXYPROPOXYVITAMIN D 3 | 14 | 100% | 0% | 7 | Search 1+ALPHA+25+DIHYDROXY+2+BETA+3+HYDROXYPROPOXYVITAMIN+D+3 | Search 1+ALPHA+25+DIHYDROXY+2+BETA+3+HYDROXYPROPOXYVITAMIN+D+3 |
8 | 2MD | 12 | 86% | 0% | 6 | Search 2MD | Search 2MD |
9 | C 24 OXIDATION PATHWAY | 12 | 86% | 0% | 6 | Search C+24+OXIDATION+PATHWAY | Search C+24+OXIDATION+PATHWAY |
10 | 1 ALPHA 25OH2 3 EPI D 3 | 11 | 100% | 0% | 6 | Search 1+ALPHA+25OH2+3+EPI+D+3 | Search 1+ALPHA+25OH2+3+EPI+D+3 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | D CALCIFEROL | 269 | 97% | 5% | 74 |
2 | A RING DIASTEREOMERS | 102 | 88% | 3% | 49 |
3 | 2 METHYL 1 25 DIHYDROXYVITAMIN D 3 | 92 | 92% | 2% | 36 |
4 | 1 ALPHA 25 DIHYDROXY 19 NORVITAMIN D 3 | 69 | 91% | 2% | 29 |
5 | CARBOXYLIC ESTER ANTAGONISTS | 65 | 90% | 2% | 28 |
6 | ED 71 | 53 | 95% | 1% | 18 |
7 | VITAMIN D CALCIFEROL | 52 | 73% | 3% | 40 |
8 | D NUCLEAR RECEPTOR | 51 | 83% | 2% | 29 |
9 | D ENDOCRINE SYSTEM | 43 | 25% | 10% | 153 |
10 | CALCITROIC ACID | 35 | 62% | 2% | 37 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
STRUCTURE-FUNCTION-RELATIONSHIPS IN THE VITAMIN-D ENDOCRINE SYSTEM | 1995 | 941 | 425 | 29% |
Organic chemistry of vitamin D analogues (deltanoids) | 2003 | 70 | 23 | 96% |
Vitamin D receptor ligands: the impact of crystal structures | 2012 | 15 | 79 | 84% |
Structure-activity relationship of nonsecosteroidal vitamin D receptor modulators | 2014 | 2 | 44 | 70% |
Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment | 2014 | 2 | 79 | 65% |
25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D | 2012 | 54 | 100 | 26% |
SYNTHESIS OF VITAMIN-D (CALCIFEROL) | 1995 | 285 | 390 | 53% |
Enantioselective synthesis of steroids | 2007 | 36 | 278 | 46% |
Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone | 2013 | 8 | 21 | 48% |
Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs | 2007 | 57 | 209 | 29% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BONE CALCIUM METAB | 24 | 91% | 0.7% | 10 |
2 | VAKGROEP ORGAN CHEM | 9 | 83% | 0.3% | 5 |
3 | INVEST IGNACIO RIBAS | 8 | 100% | 0.3% | 5 |
4 | HYG SCI | 8 | 23% | 1.9% | 29 |
5 | TEIJIN BIOMED | 7 | 26% | 1.5% | 23 |
6 | SYNTHET TECHNOL | 6 | 71% | 0.3% | 5 |
7 | EXPT GENEESKUNDE ENDOCRINOL | 6 | 26% | 1.3% | 19 |
8 | HYG CHEM NUTR | 4 | 50% | 0.4% | 6 |
9 | ONDERWIJS NAVORSING GASTHUISBERG | 3 | 60% | 0.2% | 3 |
10 | PRECLIN DRUG | 2 | 44% | 0.3% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000208104 | 24 25 DIHYDROXYVITAMIN D 3//25 HYDROXYVITAMIN D 24 HYDROXYLASE//24 25 DIHYDROXYVITAMIN D3 |
2 | 0.0000157151 | VITAMIN D RECEPTOR//VDR//EB1089 |
3 | 0.0000141835 | ORTHOQUINODIMETHANE//ANGULAR TRIFLUOROMETHYL GROUP//D HOMO STEROID SYNTHESIS |
4 | 0.0000130847 | CYCLONERODIOL//STAPPIA SP//3R 4S 4 HYDROXYMELLEIN |
5 | 0.0000126572 | 1 ALPHA 25OH2D 3//CHONDROCYTE CULTURES//RAPID ACTIONS |
6 | 0.0000088652 | HEREDITARY VITAMIN D RESISTANT RICKETS//VITAMIN D DEPENDENT RICKETS TYPE II//MED ENDOCRINOL BRANCH |
7 | 0.0000071127 | DIETARY CA RESTRICTION//ZURICH OSTEOPOROSIS GRP//1 ALPHA HYDROXYVITAMIN D 3 |
8 | 0.0000070502 | RETINOYLATION//RETINOBENZOIC ACID//RXR |
9 | 0.0000069670 | WESTPHALEN REARRANGEMENT//IMIDE REDUCTION//FOSSIL BIOMARKERS |
10 | 0.0000068061 | CALCIPOTRIOL//BETAMETHASONE DIPROPIONATE//TACALCITOL |